Sequencing

Two research groups demonstrated the de novo assembly of a human genome and a tomato genome, using data from Oxford Nanopore's MinIon.

The University of Edinburgh analyzed more than 6,000 genomes in a year, an effort made possible by a computing center dubbed a "genome factory" by its director.

Pacific Biosciences reported total Q1 2017 revenues of $24.9 million, just beating analysts' average estimate of $24.6 million. 

The team's assembly represents 95 percent of the genomic sequence of barley, the most complete version of that genome to date. 

The two studies came out of the UK's Tracking Cancer Evolution through Therapy (TRACERx) trial.

Reagent cartridge
Pretreatment method of biological sample, detection method of RNA, and pretreatment kit
Methods and compositions for identifying enterovirus
Method for direct amplification from crude nucleic acid samples
Base-by-base ratcheting of DNA/RNA in a Y-shaped nanochannel
Methods for suppression PCR

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
11
Sponsored by
PerkinElmer

This webinar will provide an overview of an RNA-seq protocol that has been optimized to study small RNA species such as microRNAs.

May
23
Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants. 

Jun
20
Sponsored by
OmniSeq

This webinar will discuss RNA sequencing as an alternative to immunohistochemistry (IHC) in selecting patients for cancer immunotherapy.